Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,608 | -26,156 | -68,300 | -32,330 | -16,190 |
| Depreciation Amortization | 2,251 | 1,109 | 3,520 | 1,670 | 1,500 |
| Accounts receivable | -715 | -3,548 | N/A | N/A | N/A |
| Other Working Capital | 1,287 | 7,286 | 17,810 | 0 | 0 |
| Other Operating Activity | -19,834 | -5,215 | -24,250 | -7,160 | -6,570 |
| Operating Cash Flow | $-66,619 | $-26,524 | $-71,220 | $-37,820 | $-21,260 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,687 | -2,633 | -27,450 | -14,130 | -15,090 |
| Purchase Sale Intangibles | -214 | -176 | N/A | N/A | N/A |
| Other Investing Activity | 53 | -73 | 190 | -7,910 | 80 |
| Investing Cash Flow | $-6,634 | $-2,706 | $-27,260 | $-22,040 | $-15,010 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -79 | -38 | N/A | N/A | N/A |
| Common Stock Issued | 898 | 833 | N/A | N/A | N/A |
| Other Financing Activity | -50 | -30 | 196,830 | 201,580 | 500 |
| Financing Cash Flow | $769 | $765 | $196,830 | $201,580 | $500 |
| Exchange Rate Effect | 11,881 | 5,475 | 9,530 | -1,080 | 12,220 |
| Beginning Cash Position | 337,394 | 347,047 | 252,110 | 258,290 | 244,260 |
| End Cash Position | 276,791 | 324,057 | 359,990 | 398,920 | 220,710 |
| Net Cash Flow | $-60,603 | $-22,990 | $107,870 | $140,630 | $-23,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,619 | -26,524 | -71,220 | -37,820 | -21,260 |
| Capital Expenditure | -6,687 | -2,633 | N/A | N/A | N/A |
| Free Cash Flow | -73,306 | -29,157 | -71,220 | -37,820 | -21,260 |